News
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
As the United States market grapples with renewed trade tensions and fluctuating indices, investors are keenly observing the impact on economic growth and corporate profits. In such a volatile ...
The U.S. market is currently experiencing heightened volatility, with major indices like the Dow Jones and Nasdaq Composite facing declines due to renewed trade tensions following President Trump's ...
13h
Clinical Trials Arena on MSNASCO25: Volastra announces first-in-human data for KIF18A inhibitorVolastra Therapeutics has announced the preliminary data of its oral kinesin family member 18A (KIF18A) inhibitor, VLS-1488, ...
Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results